Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Audrey Gallud is active.

Publication


Featured researches published by Audrey Gallud.


Advanced Materials | 2014

Biodegradable Ethylene‐Bis(Propyl)Disulfide‐Based Periodic Mesoporous Organosilica Nanorods and Nanospheres for Efficient In‐Vitro Drug Delivery

Jonas G. Croissant; Xavier Cattoën; Michel Wong Chi Man; Audrey Gallud; Laurence Raehm; Philippe Trens; Marie Maynadier; Jean-Olivier Durand

Periodic mesoporous organosilica nanorods and nanospheres are synthesized from 1,4-bis(triethoxysilyl)ethylene and bis(3-ethoxysilylpropyl)disulfide. The nanosystems present the long-range order of the hexagonal nanostructure. They are degraded in simulated physiological conditions. The loading and release of doxorubicin with these nanosystems are both pH dependent. These nanoparticles are endocytosed by breast cancer cells and are very efficient for doxorubicin delivery in these cells.


Small | 2014

Two‐Photon‐Triggered Drug Delivery via Fluorescent Nanovalves

Jonas G. Croissant; Arnaud Chaix; Olivier Mongin; Miao Wang; Sébastien Clément; Laurence Raehm; Jean-Olivier Durand; Vincent Hugues; Mireille Blanchard-Desce; Marie Maynadier; Audrey Gallud; Magali Gary-Bobo; Marcel Garcia; Jie Lu; Fuyuhiko Tamanoi; Daniel P. Ferris; Derrick Tarn; Jeffrey I. Zink

Mesoporous silica nanoparticles (MSN) are functionalized in the walls with an original fluorophore with a high two-photon absorption cross-section. The pores of the MSN filled with anticancer drug are blocked with a pseudo-rotaxane constituted by an azobenzene stalk and a β-cyclodextrin moiety. After incubation of the nanosystem with MCF-7 breast cancer cells, two-photon irradiation at low power is used to image the cells. At high power, cancer cell killing is observed due to the two-photon-triggered opening of the pores through FRET and the release of the anticancer drug from the MSN.


Advanced Materials | 2014

Two‐Photon Excitation of Porphyrin‐Functionalized Porous Silicon Nanoparticles for Photodynamic Therapy

Emilie Secret; Marie Maynadier; Audrey Gallud; Arnaud Chaix; Elise Bouffard; Magali Gary-Bobo; Nathalie Marcotte; Olivier Mongin; Khaled El Cheikh; Vincent Hugues; Mélanie Auffan; Céline Frochot; Alain Morère; Philippe Maillard; Mireille Blanchard-Desce; Michael J. Sailor; Marcel Garcia; Jean-Olivier Durand; Frédérique Cunin

Porous silicon nanoparticles (pSiNPs) act as a sensitizer for the 2-photon excitation of a pendant porphyrin using NIR laser light, for imaging and photodynamic therapy. Mannose-functionalized pSiNPs can be vectorized to MCF-7 human breast cancer cells through a mannose receptor-mediated endocytosis mechanism to provide a 3-fold enhancement of the 2-photon PDT effect.


Angewandte Chemie | 2013

Two-Photon-Triggered Drug Delivery in Cancer Cells Using Nanoimpellers†

Jonas G. Croissant; Marie Maynadier; Audrey Gallud; Harmel W. Peindy N'dongo; Jeff L. Nyalosaso; Gaelle Derrien; Clarence Charnay; Jean-Olivier Durand; Laurence Raehm; Françoise Serein-Spirau; Nathalie Cheminet; Thibaut Jarrosson; Olivier Mongin; Mireille Blanchard-Desce; Magali Gary-Bobo; Marcel Garcia; Jie Lu; Fuyuhiko Tamanoi; Derrick Tarn; Tania M. Guardado-Alvarez; Jeffrey I. Zink

A therapy of cancer cells: Two-photon-triggered camptothecin delivery with nanoimpellers was studied in MCF-7 breast cancer cells. A fluorophore with a high two-photon absorption cross-section was first incorporated in the nanoimpellers. Fluorescence resonance energy transfer (FRET) from the fluorophore to the azobenzene moiety was demonstrated.


International Journal of Pharmaceutics | 2012

Multifunctionalized mesoporous silica nanoparticles for the in vitro treatment of retinoblastoma: Drug delivery, one and two-photon photodynamic therapy

Magali Gary-Bobo; Youssef Mir; Cédric Rouxel; David Brevet; Ouahiba Hocine; Marie Maynadier; Audrey Gallud; Afitz Da Silva; Olivier Mongin; Mireille Blanchard-Desce; Sébastien Richeter; Bernard Loock; Philippe Maillard; Alain Morère; Marcel Garcia; Laurence Raehm; Jean-Olivier Durand

In this work, we focused on mesoporous silica nanoparticles (MSN) for one photon excitated photodynamic therapy (OPE-PDT) combined with drug delivery and carbohydrate targeting applied on retinoblastoma, a rare disease of childhood. We demonstrate that bitherapy (camptothecin delivery and photodynamic therapy) performed with MSN on retinoblastoma cancer cells was efficient in inducing cancer cell death. Alternatively MSN designed for two-photon excited photodynamic therapy (TPE-PDT) were also studied and irradiation at low fluence efficiently killed retinoblastoma cancer cells.


Chemical Communications | 2013

Anionic porphyrin-grafted porous silicon nanoparticles for photodynamic therapy

Emilie Secret; Marie Maynadier; Audrey Gallud; Magali Gary-Bobo; Arnaud Chaix; Emmanuel Belamie; Philippe Maillard; Michael J. Sailor; Marcel Garcia; Jean-Olivier Durand; Frédérique Cunin

Non-toxic porous silicon nanoparticles carry porphyrin covalently attached to their surface inside breast cancer cells for a more efficient photodynamic effect.


Small | 2015

Enhanced Two‐Photon Fluorescence Imaging and Therapy of Cancer Cells via Gold@Bridged Silsesquioxane Nanoparticles

Jonas G. Croissant; Marie Maynadier; Olivier Mongin; Vincent Hugues; Mireille Blanchard-Desce; Arnaud Chaix; Xavier Cattoën; Michel Wong Chi Man; Audrey Gallud; Magali Gary-Bobo; Marcel Garcia; Laurence Raehm; Jean-Olivier Durand

A two-photon photosensitizer with four triethoxysilyl groups is synthesized through the click reaction. This photosensitizer allows the design of bridged silsesquioxane (BS) nanoparticles through a sol-gel process; moreover, gold core BS shells or BS nanoparticles decorated with gold nanospheres are synthesized. An enhancement of the two-photon properties is noted with gold and the nanoparticles are efficient for two-photon imaging and two-photon photodynamic therapy of cancer cells.


Chemistry: A European Journal | 2014

Hybrid mesoporous silica nanoparticles with pH-operated and complementary H-bonding caps as an autonomous drug-delivery system.

Christophe Théron; Audrey Gallud; Carole Carcel; Magali Gary-Bobo; Marie Maynadier; Marcel Garcia; Jie Lu; Fuyuhiko Tamanoi; Jeffrey I. Zink; Michel Wong Chi Man

Mesoporous silica nanoparticles (MSNPs) are functionalized with molecular-recognition sites by anchoring a triazine or uracil fragment on the surface. After loading these MSNPs with dyes (propidium iodide or rhodamine B) or with a drug (camptothecin, CPT) they are capped by the complementary fragments, uracil and adenine, respectively, linked to the bulky cyclodextrin ring. These MSNPs are pH-sensitive and indeed, the dye release was observed at acidic pH by continuously monitored fluorescence spectroscopy studies. On the other hand, no dye leakage occurred at neutral pH, hence meeting the non-premature requirement to minimize side effects. In vitro studies were performed and confocal microscopy images demonstrate the internalization of the MSNPs and also dye release in the cells. To investigate the drug-delivery performance, the cytotoxicity of CPT-loaded nanoparticles was tested and cell death was observed. A remarkably lower amount of loaded CPT in the MSNPs (more than 40 times less) proved to be as efficient as free CPT. These results not only demonstrate the drug release after pore opening under lysosomal pH, but they also show the potential use of these MSNPs to significantly decrease the amount of the administered drug.


European Journal of Medicinal Chemistry | 2014

Imidazopyridine-fused [1,3]-diazepinones: synthesis and antiproliferative activity.

Audrey Gallud; Ophélie Vaillant; Ludovic T. Maillard; Dominique P. Arama; Joëlle Dubois; Marie Maynadier; Vincent Lisowski; Marcel Garcia; Jean Martinez; Nicolas Masurier

A series of 15 pyrido-imidazo-1,3-diazepin-5-ones and pyrido-1,3-diazepine-2,5-diones were synthesized and their anticancer activities were evaluated. Among tested compounds on a cell lines panel, compound 6a presents the best growth inhibition activity on 21 cell lines with a cytotoxic effect on MDA-MB-435 melanoma cells. This compound led to deep cell morphological changes and revealed to be an inhibitor of the Hepatocyte progenitor kinase-like kinase (HGK), which is known to be implicated in the migration, adhesion and invasion of various tumor cells.


Current Medicinal Chemistry | 2013

Targeting Multiplicity: The Key Factor for Anti-Cancer Nanoparticles

Magali Gary-Bobo; Ophélie Vaillant; Marie Maynadier; Ilaria Basile; Audrey Gallud; K. El Cheikh; Elise Bouffard; Alain Morere; X. Rebillard; P. Puche; Philippe Nirdé; Marcel Garcia

In this mini-review, we focus on different strategies to bring nanotools specifically to cancer cells. We discuss about a better targeting of tumor, combining the characteristics of tumor environment, the increase in nanoparticles life time, the biomarkers overexpressed on cancer cells and different physical methods for non invasive therapies. Here we detail the necessity of a synergy between passive and active targeting for an actual specificity of cancer cells.

Collaboration


Dive into the Audrey Gallud's collaboration.

Top Co-Authors

Avatar

Marcel Garcia

University of Montpellier

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Marie Maynadier

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar

Jean-Olivier Durand

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar

Laurence Raehm

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar

Olivier Mongin

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Alain Morère

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar

Arnaud Chaix

École Normale Supérieure

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge